Navigation Links
Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation

.eu.int.

About Centocor

Centocor is harnessing the power of world-leading research and biomanufacturing to deliver innovative biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis.

The world leader in monoclonal antibody production and technology, Centocor has brought critical biologic therapies to patients suffering from debilitating immune disorders. Centocor, Inc. is a wholly owned subsidiary of Johnson & Johnson.

This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnson's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 31, 2006. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statements as a result of new information or future events or develo
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
2. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
3. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
4. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
5. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
6. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
7. Inimex Product Candidate is First Immune Defense Regulator to Cure Infections Without Causing Harmful Inflammation
Post Your Comments:
(Date:12/17/2009)... -- The Make-A-Wish Foundation announced today that it ... LATISSE ® Wishes ... ,, Based on the tradition of blowing on ... the campaign launched earlier this year to raise ... leveraging the excitement around the availability of LATISSE® ...
(Date:12/16/2009)... Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: ... 2010 the U.S. Food and Drug Administration,s ... the New Drug Application (NDA) for pixantrone ... lymphoma (NHL). ODAC is an independent panel ... efficacy and safety of marketed and investigational ...
(Date:12/16/2009)... 16 MedSolutions ( www.medsolutions.com ), a ... commended two new studies highlighting the dangers of ... diagnostic imaging tests. ,, "When used properly, ... treatment," said Gregg Allen, M.D., chief medical officer ... compelling evidence that stricter quality control measures are ...
Breaking Medicine Technology:The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 2The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 3The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 4The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign 5Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 2Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 3Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 4MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3Cardio Vascular Medical Device to Apply for Additional Patents in Europe Canada and Far East 61861 1Cardio Vascular Medical Device to Apply for Additional Patents in Europe Canada and Far East 61861 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 1Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 6445 4High blood pressure easy to miss in children with kidney disease 61855 1High blood pressure easy to miss in children with kidney disease 61855 2
... 21, 2007 - Neurologix, Inc.,(OTCBB:NRGX) today announced the ... The Lancet of positive results from the first ... first report of,direct gene transfer into a patient's ... open label Phase 1 study, conducted in 12 ...
... 21, 2007 - The,PromegaExpress(TM) on-site stocking program just ... of on-site appliances. This,latest addition serves as great ... areas when space is at a premium,but immediate ... The,mid-sized cabinet can also be stacked with another ...
Other Medicine Technology:Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6
(Date:12/17/2009)... -- Fred Hutchinson Cancer Research Center scientist M. ... awarded the distinction of AAAS Fellow. Election as ... of the American Association for the Advancement of ... is a researcher in the Hutchinson Center,s Vaccine ... biostatistics at the University of Washington. She is ...
(Date:12/17/2009)... Pacific Shore Holdings, Inc., manufacturers of ... the launch of their new Thermal-Aid product line. ... specifically designed to reduce swelling and relieve pain ... applications. Researchers behind Thermal-Aid created a line of ... temperatures for long periods of time, making a ...
(Date:12/17/2009)... Respect for Life" in Majority Leader,s Revisions to ... WASHINGTON, Dec. 17 Americans United for ... letter today to Senate Majority Leader Harry Reid ... Majority Leader,s revisions to a bill - to ... Senator Reid to include "specific language that ensures ...
(Date:12/17/2009)... it comes from physician, study finds , , THURSDAY, Dec. ... most influence in convincing parents to place infants on ... prevent sudden infant death syndrome, or SIDS, researchers have ... to Sleep" campaign in 1994, the number of infants ... from 25 percent to 70 percent, and the rate ...
(Date:12/17/2009)... improved, but Americans fall down on prevention, experts ... While physicians and surgeons are getting better at ... many Americans are ignoring the basic rules for ... American Heart Association. , Topping the list: too ... 59 percent of adults surveyed last year reported ...
Breaking Medicine News(10 mins):Health News:M. Elizabeth Halloran Named AAAS Fellow 2Health News:M. Elizabeth Halloran Named AAAS Fellow 3Health News:M. Elizabeth Halloran Named AAAS Fellow 4Health News:Thermal-Aid Bears Provide Warm Comfort to Children at Penny Lane for the Holidays 2Health News:Pro-Life Leader Sends Urgent Letter to Senator Reid 2Health News:Doctor's Orders Influence Baby's Sleep Position 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 3
... health and vitality. However, just a small amount of sunlight ... doesn't take much sunlight to make all the vitamin D ... to get a suntan. ,Recently, a study was conducted ... (UVL) tanning behavior. For the study, researchers at the University ...
... India and sponsored by Colgate-Palmolive (India) Ltd says that even ... available in the market, //the level of oral hygiene awareness ... that they have never been to a dentist in their ... practices are resulting in a myriad of dental problems across ...
... the widespread incidence of AIDS, Zambia has initiated clinical ... that one in every six Zambians are afflicted with ... the efficacy of herbal remedies in the treatment of ... which three have been approved. The trial would be ...
... visual spatial processing, memory, and cognitive proficiency are consequences ... alcoholics than the general population,// yet the possible neurocognitive ... studied, despite evidence that long-term smoking is associated with ... A research team ...
... claim that some head and neck cancer patients can safely ... scan.// This scan can predict whether the cancer is under ... were presented at the annual meeting of the American Society ... resident in radiation oncology at the UF Shands Cancer Center ...
... loss of sexual interest have often been associated with ... men who are long-term alcohol users,// with the prevalence ... cause gonadal disorders, including structural testicular changes and a ... might be involved in the hypogonadism and feminization phenotype. ...
Other Medicine News:Health News:Detrimental Effect Of Chronic Alcoholism On Male Fertility 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: